We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vectura Group Plc | LSE:VEC | London | Ordinary Share | GB00BKM2MW97 | ORD 0.0271P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 164.80 | 164.80 | 165.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
14/2/2017 13:41 | Will this weakness get bought into....drum roll | richtea1701 | |
13/2/2017 15:25 | Sorting out the litigation with GSK would go down well. Never a good thing to be suing one of your key customers! | fhmktg | |
13/2/2017 14:22 | Perhaps there's something to our advantage in the background that we don't know about at the mo! | popper joe | |
13/2/2017 13:59 | Good momentum on good volumes... obviously there's nothing untoward in the background that we don't know about at the mo. | dontay | |
13/2/2017 11:31 | Momentum with VEC at the moment, no chartist but a break of 151p(ish) would look fairly bullish........ | soundbuy | |
10/2/2017 12:28 | FWI Chart looks a bit healthier 50day MVA 137.45, 90day MVA 138.2 and 200 day MVA 145.82. AO | a0148009 | |
10/2/2017 10:31 | Careful, don't rock the boat! | diesel | |
10/2/2017 10:16 | cap160-same answer except I don't have to think! | alexchry | |
10/2/2017 09:49 | Ermmm---let me think----nah! | cap160 | |
10/2/2017 08:59 | Ah but dont you miss those cold damp misty mornings, the busy roads etc ? | pooroldboy55 | |
10/2/2017 08:25 | And here in New Zealand POB and alexry---and nice to see a bit of a re trace..... | cap160 | |
10/2/2017 07:25 | 160p is the share price at which I'll feel a lot happier about VEC, it's approx the price at the time of the merger. I didn't sell then as I expected the share price to rise as the merger got under way. Since then the bad and the delayed news has contributed to the share price weakness but, as I said previously, I am starting to feel warmer about the share price POB-a lot warmer here in Melbourne. | alexchry | |
09/2/2017 17:46 | Good to see 140 re-taken but most folk on here won't be cheering too loudly until we're closing on the 160p price range and recovery on tack. May will have a lot to do with that, and we're not talking Theresa. | carpadium | |
09/2/2017 14:06 | Excellent review and well received.Roll on the Advair generic approval!Chinese copd report shouldn't be long..... | fhmktg | |
09/2/2017 12:46 | Corporate Presentation February 2017. AO | a0148009 | |
09/2/2017 12:18 | With Trump pressuring the Pharmas and number of players competing margins are bound to fall. AO | a0148009 | |
09/2/2017 12:02 | Hi alex , Keeping my head down at the moment you could be right warmer.But bloody cold here in north oxon!!!!!! | pooroldboy55 | |
09/2/2017 11:23 | pob-where are you, expecting you to come in with your up am-down pm prediction. I don't know why but I just have a much warmer feeling about the share price than I have for a while, just hope that I haven't spoken too soon. | alexchry | |
03/2/2017 13:48 | I'm saying nothing.... | diesel | |
02/2/2017 20:57 | hashertu, yes... and it gets even more complex when a particular drug is licensed for only once a day use in one part of the world, as in that last USA approval... but has been given the OK for twice a day for the rest of the world! Due to the vital requirement to ensure patient dosages are correct the inhaler device type also has to change. Add into the equation that a drug maybe ok for asthma and COPD in one part of the world but only deemed good for asthma somewhere else... drug marketing names change and so do device names... and the whole subject gets rather mind boggling! Well... mine does :) | dontay | |
02/2/2017 15:01 | thsts more like back to normal down pm | pooroldboy55 | |
02/2/2017 11:05 | Dontay. Thanks for the reply. My question was prompted by the Sunovion/Novartis announcement (21 Dec). The products listed seemed to be quite specific, but similar sounding. I wondered if there were some sub-text here, like, the products licensed were older, or lower margin. Or, perhaps, there is some benefit in having a US company name on the packaging. | hashertu | |
02/2/2017 10:07 | Maybe just an er? Just a bit of irrational exhuberance. | diesel |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions